Regulations.gov document
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
Rule · FDA-2021-N-0862 · posted Dec 26, 2024
Key facts
| Document ID | FDA-2021-N-0862-0207 |
|---|---|
| Title | Nonprescription Drug Product With an Additional Condition for Nonprescription Use |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2021-N-0862 |
| Posted | Dec 26, 2024 |
| Federal Register citation | 89 FR 105288 |
| FR document number | 2024-30261 |
| CFR | 21 CFR Parts 201 and 314 |
| Comment period opens | Dec 26, 2024 |
| Effective date | Dec 26, 2024 |
At a glance
- 10–99 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: